INHSU Prisons

INHSU Prisons was a special interest group for INHSU members to participate in scientific knowledge and information exchange, knowledge translation, and advocacy for enhanced hepatitis care in custodial settings.

INHSU Prisons was discontinued in late 2024, with prisons-related work now integrated into our core program. This change reflects the significant progress and efforts of the Prisons SIG since its launch in 2019, driving research, advocacy, and awareness of hepatitis and broader health issues in custodial settings.

By embedding prison work into INHSU’s broader program of work, we aim to create more opportunities for engagement in prison topics, including topics beyond viral hepatitis in prisons.

History of INHSU Prisons

The group was established in 2019 and held its inaugural annual workshop in association with INHSU 2019 in Montreal.

Formed to connect the global community working to enhance access to hepatitis care for people in prisons, INHSU Prisons brought together researchers, practitioners, policymakers, advocates and affected communities to improve the health of people in custodial settings.

 

 

The SIG aimed to:

  1. Facilitate information exchange at the international level to enhance the capacity of prison-based health systems for HCV prevention and care 
  2. Develop prison-focused HCV education programs adapted to diverse prison settings worldwide
  3. Facilitate translation of health services research to support advocacy and drive policymaking, to improve HCV prevention and care efforts in prisons

INHSU Prisons Activities

INHSU Prisons Executive Committee

We thank the Prisons Executive Committee for their tireless efforts. Prisons content will continue to be a focus of INHSU and incorporated into the wider INHSU programming.

 

  • Chair: Professor Andrew Lloyd, Australian National Prisons Hepatitis Network / The Kirby Institute UNSW Sydney, Australia
  • Vice-Chair: Dr Matthew Akiyama, Albert Einstein College of Medicine / Montefiore Medical Centre, New York, USA
  • Vice-Chair: Dr Joaquin Cabezas, Marques de Valdecilla University Hospital, Santander, Spain
  • Vice-Chair: Dr Nadine Kronfli, McGill University Health Centre, Montreal, Quebec, Canada
  • Early Career Representative: Yumi Sheehan, Australian National Prisons Hepatitis Network / The Kirby Institute UNSW Sydney, Australia
  • Julia Sheehan, The Hepatitis C Trust, London, United Kingdom
  • Nonso B.C Maduka, Bensther Development Foundation, Nigeria